Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Latest news
The Questions Doctors Are Getting About Aduhelm Right Now—And Their Answers
Neuroscientist Lisa Genova: How to Spot — and Prevent — Memory Loss
Dementia Caregiver Checklist: 6 Things Every Caregiver Needs to Know
Will Insurance Companies and Medicare Cover Aduhelm’s High Price Tag?
‘Cautiously Optimistic:’ Cancer Drug Sargramostim May Improve Memory in Alzheimer’s
A Retired Neurologist’s on His Own Alzheimer’s Journey
A Retired Neurologist On His Experience With Aduhelm’s Side Effects
Trial and Lots of Error: Experts Say Alzheimer’s Clinical Trials Need a Rethink
Olympic Gold Medalist Imran Sherwani Reveals Early-Onset Alzheimer’s Diagnosis
Amyloid Hypothesis in the Hot Seat After Aduhelm Approved for Alzheimer’s
What is an Aduhelm Infusion, and Why Was Its Approval So Controversial?
What Is Aduhelm and How Does It Fight Alzheimer’s?
Phil’s Journal: Aduhelm Is Greenlit to Treat Alzheimer’s—It’s Still Complicated
Q&A: Dr. Eric Larson on Ways to Lower Dementia Risk—and Why They Work
Experts Respond to Aduhelm Approval
Previous
81
82
83
Next
Page load link
Go to Top